The Institute features state-of-the-art core technologies at the University of Chicago and Argonne National Laboratory. These facilities support efforts to define the complex genetics underlying disease, the development of potential therapeutics to target disease pathways and the engineering of biological systems for the production of alternative energy.

Current and upcoming facilities include:
• IGSB Celluar Screening Center (CSC)
• — high-throughput RNAi and chemical genetic screening
  [more info]
• IGSB High-throughput Genome Analysis Core (HGAC)
• — tiling and expression arrays for large-scale experiments
• — sequencing using the speed and cost efficiency of the latest technologies including Solexa and 454
  [more info]
• IGSB Proteomics Core
• — high-throughput cloning and protein production facilities for antibody generation
• — an integrated suite of instrumentation that allows for the rapid synthesis and purification of peptides housed within the laboratory of IGSB Core Member Richard B. Jones
  [more info]

Any questions regarding the Institute's facilities should be addressed to Dr. Aharon Solomon, IGSB Research Director (asolomon@uchicago.edu 773 834 3882).

The Institute is also collaborating with Partner Facilities at the University, Argonne and other Chicago institutions to provide IGSB researchers with the most comprehensive and technologies currently available.
[more info]